SYRS — Syros Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Syros Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	91.4	174	130	202	140
Net Total Accounts Receivable
Net Total Receivables	20.2	2.33	2.98	1.69	0
Prepaid Expenses
Total Other Current Assets
Total Current Assets	115	179	137	211	145
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	31.9	29.6	27.3	24.7	19.5
Long Term Investments
Other Long Term Assets
Total Assets	150	213	183	244	168
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	23.5	28.6	31.5	30.8	36.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	70.8	123	97.7	117	152
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	79.2	90.6	85.2	128	16.7
Total Liabilities & Shareholders' Equity	150	213	183	244	168
Total Common Shares Outstanding